Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Song, Han | - |
dc.contributor.author | Yoo, Young | - |
dc.contributor.author | Hwang, Junghyun | - |
dc.contributor.author | Na, Yun-Cheol | - |
dc.contributor.author | Kim, Heenam Stanley | - |
dc.date.accessioned | 2021-09-04T02:18:12Z | - |
dc.date.available | 2021-09-04T02:18:12Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2016-03 | - |
dc.identifier.issn | 0091-6749 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/89419 | - |
dc.description.abstract | Background: Atopic dermatitis (AD) is a serious global epidemic associated with a modern lifestyle. Objective: Although aberrant interactions between gut microbes and the intestinal immune system have been implicated in this skin disease, the nature of the microbiome dysfunction underlying the disease remains unclear. Methods: The gut microbiome from 132 subjects, including 90 patients with AD, was analyzed by using 16S rRNA gene and metagenome sequence analyses. Reference genomes from the Human Microbiome Project and the KEGG Orthology database were used for metagenome analyses. Short-chain fatty acids in fecal samples were compared by using gas chromatographic-mass spectrometric analyses. Results: We show that enrichment of a subspecies of the major gut species Faecalibacterium prausnitzii is strongly associated with AD. In addition, the AD microbiome was enriched in genes encoding the use of various nutrients that could be released from damaged gut epithelium, reflecting a bloom of auxotrophic bacteria. Fecal samples from patients with AD showed decreased levels of butyrate and propionate, which have anti-inflammatory effects. This is likely a consequence of an intraspecies compositional change in F prausnitzii that reduces the number of high butyrate and propionate producers, including those related to the strain A2-165, a lack of which has been implicated in patients with Crohn disease. Conclusions: The data suggest that feedback interactions between dysbiosis in F prausnitzii and dysregulation of gut epithelial inflammation might underlie the chronic progression of AD by resulting in impairment of the gut epithelial barrier, which ultimately leads to aberrant T(H)2-type immune responses to allergens in the skin. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MOSBY-ELSEVIER | - |
dc.subject | ESCHERICHIA-COLI | - |
dc.subject | INTESTINAL MICROBIOTA | - |
dc.subject | OXIDATIVE STRESS | - |
dc.subject | IRRITABLE-BOWEL | - |
dc.subject | HIGH-THROUGHPUT | - |
dc.subject | DISEASE | - |
dc.subject | CLASSIFICATION | - |
dc.subject | DYSFUNCTION | - |
dc.subject | METABOLISM | - |
dc.subject | PREBIOTICS | - |
dc.title | Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yoo, Young | - |
dc.contributor.affiliatedAuthor | Kim, Heenam Stanley | - |
dc.identifier.doi | 10.1016/j.jaci.2015.08.021 | - |
dc.identifier.scopusid | 2-s2.0-84945554698 | - |
dc.identifier.wosid | 000371897500029 | - |
dc.identifier.bibliographicCitation | JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, v.137, no.3, pp.852 - 860 | - |
dc.relation.isPartOf | JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | - |
dc.citation.title | JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | - |
dc.citation.volume | 137 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 852 | - |
dc.citation.endPage | 860 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Allergy | - |
dc.relation.journalResearchArea | Immunology | - |
dc.relation.journalWebOfScienceCategory | Allergy | - |
dc.relation.journalWebOfScienceCategory | Immunology | - |
dc.subject.keywordPlus | ESCHERICHIA-COLI | - |
dc.subject.keywordPlus | INTESTINAL MICROBIOTA | - |
dc.subject.keywordPlus | OXIDATIVE STRESS | - |
dc.subject.keywordPlus | IRRITABLE-BOWEL | - |
dc.subject.keywordPlus | HIGH-THROUGHPUT | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordPlus | CLASSIFICATION | - |
dc.subject.keywordPlus | DYSFUNCTION | - |
dc.subject.keywordPlus | METABOLISM | - |
dc.subject.keywordPlus | PREBIOTICS | - |
dc.subject.keywordAuthor | Atopic dermatitis | - |
dc.subject.keywordAuthor | gut microbiota | - |
dc.subject.keywordAuthor | microbiome | - |
dc.subject.keywordAuthor | dysbiosis | - |
dc.subject.keywordAuthor | Faecalibacterium prausnitzii | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.